FindTrial
Sign In

Tumor Marker CA-19-9, CEA,CA125, CA242 for early diagnosis and predicting prognosis in gall bladder cancer patient

Assessment of tumor markers; CA-19-9, CEA,CA125, CA242 for early diagnosis and predicting prognosis in gall bladder cancer patient

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/03/018064
Enrollment
200
Registered
2019-03-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K828- Other specified diseases of gallbladder

Interventions

Intervention1: NIL: NIL

Sponsors

Director
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients suspicious for gallbladder cancer ( GB polyp, irregular thick wall GB, GB mass, porcelain GB) basis of radio logical imaging

Exclusion criteria

Exclusion criteria: 1.Patients presented with GB mass with Jaundice 2.Disseminated GBC 3.Patients already received Radiotherapy/ Neoadjuvant chemotherapy 4.Synchronous second primary cancer

Design outcomes

Primary

MeasureTime frame
Access whether the combined use of tumor markers increase the diagnostic sensitivity and specificity for gallbladder cancerTimepoint: 15th April 2019 (At 1 year)—

Secondary

MeasureTime frame
To compare the tumor marker level between carcinoma of gall bladder and benign gall bladder diseases.Timepoint: January 20121 (at 2 years)—

Countries

India

Contacts

Public ContactPREM PRAKASH

Indira Gandhi Institute Of Medical Sciences

drpremprakash01@gmail.com9801276237

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026